FDA Marketing Rules Stretch To Drugmakers' Media Pitches
The U.S. Food and Drug Administration recently scolded Cornerstone Therapeutics Inc. for failing to include information about a drug's risks in a letter seeking publicity from media outlets, an unusual warning...To view the full article, register now.
Already a subscriber? Click here to view full article